-
1
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
-
[1] Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:9438 (2004), 937–952.
-
(2004)
Lancet
, vol.364
, Issue.9438
, pp. 937-952
-
-
Yusuf, S.1
Hawken, S.2
Ounpuu, S.3
Dans, T.4
Avezum, A.5
Lanas, F.6
-
2
-
-
0034700631
-
The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease
-
[2] Maron, D.J., The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am. J. Cardiol. 86:12A (2000), 11L–14L.
-
(2000)
Am. J. Cardiol.
, vol.86
, Issue.12A
, pp. 11L-14L
-
-
Maron, D.J.1
-
3
-
-
0035806916
-
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study
-
[3] Sharrett, A.R., Ballantyne, C.M., Coady, S.A., Heiss, G., Sorlie, P.D., Catellier, D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circulation 104:10 (2001), 1108–1113.
-
(2001)
Circulation
, vol.104
, Issue.10
, pp. 1108-1113
-
-
Sharrett, A.R.1
Ballantyne, C.M.2
Coady, S.A.3
Heiss, G.4
Sorlie, P.D.5
Catellier, D.6
-
4
-
-
1542361567
-
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update
-
[4] Gotto, A.M. Jr., Brinton, E.A., Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J. Am. Coll. Cardiol. 43:5 (2004), 717–724.
-
(2004)
J. Am. Coll. Cardiol.
, vol.43
, Issue.5
, pp. 717-724
-
-
Gotto, A.M.1
Brinton, E.A.2
-
5
-
-
84949672279
-
HDL particle number and size as predictors of cardiovascular disease
-
[5] Kontush, A., HDL particle number and size as predictors of cardiovascular disease. Front. Pharmacol., 6, 2015, 218.
-
(2015)
Front. Pharmacol.
, vol.6
, pp. 218
-
-
Kontush, A.1
-
6
-
-
84888203299
-
Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities
-
[6] Camont, L., Lhomme, M., Rached, F., Le Goff, W., Negre-Salvayre, A., Salvayre, R., et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler. Thromb. Vasc. Biol. 33:12 (2013), 2715–2723.
-
(2013)
Arterioscler. Thromb. Vasc. Biol.
, vol.33
, Issue.12
, pp. 2715-2723
-
-
Camont, L.1
Lhomme, M.2
Rached, F.3
Le Goff, W.4
Negre-Salvayre, A.5
Salvayre, R.6
-
7
-
-
80053574090
-
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
-
[7] Camont, L., Chapman, M.J., Kontush, A., Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17:10 (2011), 594–603.
-
(2011)
Trends Mol. Med.
, vol.17
, Issue.10
, pp. 594-603
-
-
Camont, L.1
Chapman, M.J.2
Kontush, A.3
-
8
-
-
33644608784
-
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
-
[8] Kontush, A., Chapman, M.J., Antiatherogenic small, dense HDL—guardian angel of the arterial wall?. Nat. Clin. Pract. Cardiovasc. Med. 3:3 (2006), 144–153.
-
(2006)
Nat. Clin. Pract. Cardiovasc. Med.
, vol.3
, Issue.3
, pp. 144-153
-
-
Kontush, A.1
Chapman, M.J.2
-
9
-
-
84930741855
-
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export
-
[9] Du, X.M., Kim, M.J., Hou, L., Le Goff, W., Chapman, M.J., Van Eck, M., et al. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ. Res. 116:7 (2015), 1133–1142.
-
(2015)
Circ. Res.
, vol.116
, Issue.7
, pp. 1133-1142
-
-
Du, X.M.1
Kim, M.J.2
Hou, L.3
Le Goff, W.4
Chapman, M.J.5
Van Eck, M.6
-
10
-
-
33750723794
-
Alterations in lipoprotein defense against oxidative stress in metabolic syndrome
-
[10] Hansel, B., Kontush, A., Bonnefont-Rousselot, D., Bruckert, E., Chapman, M.J., Alterations in lipoprotein defense against oxidative stress in metabolic syndrome. Curr. Atheroscler. Rep. 8:6 (2006), 501–509.
-
(2006)
Curr. Atheroscler. Rep.
, vol.8
, Issue.6
, pp. 501-509
-
-
Hansel, B.1
Kontush, A.2
Bonnefont-Rousselot, D.3
Bruckert, E.4
Chapman, M.J.5
-
11
-
-
16844382469
-
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia
-
[11] Nobecourt, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M.J., et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia 48:3 (2005), 529–538.
-
(2005)
Diabetologia
, vol.48
, Issue.3
, pp. 529-538
-
-
Nobecourt, E.1
Jacqueminet, S.2
Hansel, B.3
Chantepie, S.4
Grimaldi, A.5
Chapman, M.J.6
-
12
-
-
40749106651
-
Why is HDL functionally deficient in type 2 diabetes?
-
[12] Kontush, A., Chapman, M.J., Why is HDL functionally deficient in type 2 diabetes?. Curr. Diab. Rep. 8:1 (2008), 51–59.
-
(2008)
Curr. Diab. Rep.
, vol.8
, Issue.1
, pp. 51-59
-
-
Kontush, A.1
Chapman, M.J.2
-
13
-
-
84871995815
-
Standards of medical care in diabetes—2013
-
[13] American, D.A., Standards of medical care in diabetes—2013. Diabetes Care 36:Suppl. 1 (2013), S11–S66.
-
(2013)
Diabetes Care
, vol.36
, pp. S11-S66
-
-
American, D.A.1
-
14
-
-
45849138530
-
Impact of freezing on high-density lipoprotein functionality
-
[14] Kekulawala, J.R., Murphy, A., D'Souza, W., Wai, C., Chin-Dusting, J., Kingwell, B., et al. Impact of freezing on high-density lipoprotein functionality. Anal. Biochem. 379:2 (2008), 213–215.
-
(2008)
Anal. Biochem.
, vol.379
, Issue.2
, pp. 213-215
-
-
Kekulawala, J.R.1
Murphy, A.2
D'Souza, W.3
Wai, C.4
Chin-Dusting, J.5
Kingwell, B.6
-
15
-
-
0027285970
-
Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects
-
[15] Lagrost, L., Gandjini, H., Athias, A., Guyard-Dangremont, V., Lallemant, C., Gambert, P., Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler. Thromb. 13:6 (1993), 815–825.
-
(1993)
Arterioscler. Thromb.
, vol.13
, Issue.6
, pp. 815-825
-
-
Lagrost, L.1
Gandjini, H.2
Athias, A.3
Guyard-Dangremont, V.4
Lallemant, C.5
Gambert, P.6
-
16
-
-
0020523662
-
Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats
-
[16] Blank, M.L., Hall, M.N., Cress, E.A., Snyder, F., Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem. Biophys. Res. Commun. 113:2 (1983), 666–671.
-
(1983)
Biochem. Biophys. Res. Commun.
, vol.113
, Issue.2
, pp. 666-671
-
-
Blank, M.L.1
Hall, M.N.2
Cress, E.A.3
Snyder, F.4
-
17
-
-
0019486232
-
A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
-
[17] Chapman, M.J., Goldstein, S., Lagrange, D., Laplaud, P.M., A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22:2 (1981), 339–358.
-
(1981)
J. Lipid Res.
, vol.22
, Issue.2
, pp. 339-358
-
-
Chapman, M.J.1
Goldstein, S.2
Lagrange, D.3
Laplaud, P.M.4
-
18
-
-
0029941224
-
Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia
-
[18] Guerin, M., Bruckert, E., Dolphin, P.J., Turpin, G., Chapman, M.J., Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 16:6 (1996), 763–772.
-
(1996)
Arterioscler. Thromb. Vasc. Biol.
, vol.16
, Issue.6
, pp. 763-772
-
-
Guerin, M.1
Bruckert, E.2
Dolphin, P.J.3
Turpin, G.4
Chapman, M.J.5
-
19
-
-
0036269506
-
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
-
[19] Guerin, M., Egger, P., Soudant, C., Le Goff, W., van Tol, A., Dupuis, R., et al. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis 163:2 (2002), 287–296.
-
(2002)
Atherosclerosis
, vol.163
, Issue.2
, pp. 287-296
-
-
Guerin, M.1
Egger, P.2
Soudant, C.3
Le Goff, W.4
van Tol, A.5
Dupuis, R.6
-
20
-
-
6344267152
-
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity
-
[20] Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M.J., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 89:10 (2004), 4963–4971.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, Issue.10
, pp. 4963-4971
-
-
Hansel, B.1
Giral, P.2
Nobecourt, E.3
Chantepie, S.4
Bruckert, E.5
Chapman, M.J.6
-
21
-
-
24644514986
-
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
-
[21] Kontush, A., de Faria, E.C., Chantepie, S., Chapman, M.J., A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 182:2 (2005), 277–285.
-
(2005)
Atherosclerosis
, vol.182
, Issue.2
, pp. 277-285
-
-
Kontush, A.1
de Faria, E.C.2
Chantepie, S.3
Chapman, M.J.4
-
22
-
-
0028883658
-
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
-
[22] Abbott, C.A., Mackness, M.I., Kumar, S., Boulton, A.J., Durrington, P.N., Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:11 (1995), 1812–1818.
-
(1995)
Arterioscler. Thromb. Vasc. Biol.
, vol.15
, Issue.11
, pp. 1812-1818
-
-
Abbott, C.A.1
Mackness, M.I.2
Kumar, S.3
Boulton, A.J.4
Durrington, P.N.5
-
23
-
-
39449100874
-
Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
-
[23] de Souza, J.A., Vindis, C., Hansel, B., Negre-Salvayre, A., Therond, P., Serrano, C.V. Jr., et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 197:1 (2008), 84–94.
-
(2008)
Atherosclerosis
, vol.197
, Issue.1
, pp. 84-94
-
-
de Souza, J.A.1
Vindis, C.2
Hansel, B.3
Negre-Salvayre, A.4
Therond, P.5
Serrano, C.V.6
-
24
-
-
74549148035
-
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
-
[24] Chapman, M.J., Le Goff, W., Guerin, M., Kontush, A., Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur. Heart J. 31:2 (2010), 149–164.
-
(2010)
Eur. Heart J.
, vol.31
, Issue.2
, pp. 149-164
-
-
Chapman, M.J.1
Le Goff, W.2
Guerin, M.3
Kontush, A.4
-
25
-
-
79960614571
-
Atlanta GUSDoHaHS. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States
-
Centers for Disease Control and Prevention
-
[25] Centers for Disease Control and Prevention, Atlanta GUSDoHaHS. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. 2011, Centers for Disease Control and Prevention.
-
(2011)
-
-
Centers for Disease Control and Prevention1
-
26
-
-
0034673999
-
The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study
-
[26] Curtiss, L.K., Bonnet, D.J., Rye, K.A., The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 39:19 (2000), 5712–5721.
-
(2000)
Biochemistry
, vol.39
, Issue.19
, pp. 5712-5721
-
-
Curtiss, L.K.1
Bonnet, D.J.2
Rye, K.A.3
-
27
-
-
33646531407
-
Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation
-
[27] Persegol, L., Verges, B., Foissac, M., Gambert, P., Duvillard, L., Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation. Diabetologia 49:6 (2006), 1380–1386.
-
(2006)
Diabetologia
, vol.49
, Issue.6
, pp. 1380-1386
-
-
Persegol, L.1
Verges, B.2
Foissac, M.3
Gambert, P.4
Duvillard, L.5
-
28
-
-
0035962077
-
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial
-
[28] Robins, S.J., Collins, D., Wittes, J.T., Papademetriou, V., Deedwania, P.C., Schaefer, E.J., et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285:12 (2001), 1585–1591.
-
(2001)
JAMA
, vol.285
, Issue.12
, pp. 1585-1591
-
-
Robins, S.J.1
Collins, D.2
Wittes, J.T.3
Papademetriou, V.4
Deedwania, P.C.5
Schaefer, E.J.6
-
29
-
-
84910024203
-
Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation
-
[29] Gomez Rosso, L., Lhomme, M., Merono, T., Sorroche, P., Catoggio, L., Soriano, E., et al. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation. Atherosclerosis 237:2 (2014), 652–660.
-
(2014)
Atherosclerosis
, vol.237
, Issue.2
, pp. 652-660
-
-
Gomez Rosso, L.1
Lhomme, M.2
Merono, T.3
Sorroche, P.4
Catoggio, L.5
Soriano, E.6
-
30
-
-
84883732971
-
Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles
-
[30] Stahlman, M., Fagerberg, B., Adiels, M., Ekroos, K., Chapman, J.M., Kontush, A., et al. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. Biochim. Biophys. Acta 1831:11 (2013), 1609–1617.
-
(2013)
Biochim. Biophys. Acta
, vol.1831
, Issue.11
, pp. 1609-1617
-
-
Stahlman, M.1
Fagerberg, B.2
Adiels, M.3
Ekroos, K.4
Chapman, J.M.5
Kontush, A.6
-
31
-
-
84876740446
-
Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study
-
[31] Wong, V.W., Tse, C.H., Lam, T.T., Wong, G.L., Chim, A.M., Chu, W.C., et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study. PLoS One, 8(4), 2013, e62885.
-
(2013)
PLoS One
, vol.8
, Issue.4
, pp. e62885
-
-
Wong, V.W.1
Tse, C.H.2
Lam, T.T.3
Wong, G.L.4
Chim, A.M.5
Chu, W.C.6
-
32
-
-
84884678009
-
Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes
-
[32] Meikle, P.J., Wong, G., Barlow, C.K., Weir, J.M., Greeve, M.A., MacIntosh, G.L., et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One, 8(9), 2013, e74341.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. e74341
-
-
Meikle, P.J.1
Wong, G.2
Barlow, C.K.3
Weir, J.M.4
Greeve, M.A.5
MacIntosh, G.L.6
-
33
-
-
84931572631
-
The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics
-
[33] Lappas, M., Mundra, P.A., Wong, G., Huynh, K., Jinks, D., Georgiou, H.M., et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia 58:7 (2015), 1436–1442.
-
(2015)
Diabetologia
, vol.58
, Issue.7
, pp. 1436-1442
-
-
Lappas, M.1
Mundra, P.A.2
Wong, G.3
Huynh, K.4
Jinks, D.5
Georgiou, H.M.6
-
34
-
-
79952836464
-
A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking
-
[34] Boslem, E., MacIntosh, G., Preston, A.M., Bartley, C., Busch, A.K., Fuller, M., et al. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem. J. 435:1 (2011), 267–276.
-
(2011)
Biochem. J.
, vol.435
, Issue.1
, pp. 267-276
-
-
Boslem, E.1
MacIntosh, G.2
Preston, A.M.3
Bartley, C.4
Busch, A.K.5
Fuller, M.6
-
35
-
-
84923886912
-
Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine
-
[35] Manukyan, L., Ubhayasekera, S.J., Bergquist, J., Sargsyan, E., Bergsten, P., Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine. Endocrinology 156:3 (2015), 802–812.
-
(2015)
Endocrinology
, vol.156
, Issue.3
, pp. 802-812
-
-
Manukyan, L.1
Ubhayasekera, S.J.2
Bergquist, J.3
Sargsyan, E.4
Bergsten, P.5
-
36
-
-
84864396455
-
Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction
-
[36] Boslem, E., Meikle, P.J., Biden, T.J., Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction. Islets 4:3 (2012), 177–187.
-
(2012)
Islets
, vol.4
, Issue.3
, pp. 177-187
-
-
Boslem, E.1
Meikle, P.J.2
Biden, T.J.3
-
37
-
-
73749083481
-
Global estimates of the prevalence of diabetes for 2010 and 2030
-
[37] Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:1 (2010), 4–14.
-
(2010)
Diabetes Res. Clin. Pract.
, vol.87
, Issue.1
, pp. 4-14
-
-
Shaw, J.E.1
Sicree, R.A.2
Zimmet, P.Z.3
|